Altimmune Target Price

See how ALT's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.12

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-06-22	Leerink PartnersThomas Smith	$10	371.7% upside
2026-04-24	Goldman SachsCorinne Johnson	$2.5	17.9% upside
2026-01-27	Barclays	$20	843.4% upside
2024-04-02	H.C. WainwrightPatrick Trucchio	$12	466% upside
2022-12-01	Goldman Sachs	$20	843.4% upside
2022-11-11	JMP Securities	$26	1126.4% upside
2022-08-31	Jefferies	$35	1550.9% upside
2022-08-30	Piper SandlerYasmeen Rahimi	$25	1079.2% upside
2022-08-17	H.C. Wainwright	$50	2258.5% upside

Altimmune (ALT) FAQ

Stockcircle tracks target price for Altimmune (ALT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Altimmune's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ALT overview so you can move from this figure to the surrounding analysis quickly.